Antibiotics Market Statistics and Analysis Detailed in Latest Research Report to 2023-2028

The latest report published by IMARC Group, titled "Antibiotics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028, ″offers a comprehensive analysis of the industry, which comprises insights on antibiotics market. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global antibiotics market size reached US$ 49.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 62.6 Billion by 2028, exhibiting a growth rate (CAGR) of 3.9% during 2023-2028.

What are Antibiotics?

Antibiotics are a class of pharmaceutical compounds designed to inhibit or kill bacteria, aiding in the treatment of bacterial infections. They are pivotal in the realms of healthcare and medicine and serve as the backbone of modern therapeutic practices. They are classified into various types based on their target sites, such as penicillins, cephalosporins, and fluoroquinolones. These medications combat bacterial growth in multiple ways. They may interfere with cell wall synthesis, protein formation, or other vital processes within bacterial cells. As a cornerstone for primary healthcare and complex surgical procedures, organ transplants, and cancer treatment, antibiotics have drastically reduced mortality rates from bacterial infections. They are extensively used in hospitals, healthcare centers, and are available for over-the-counter purchase for minor infections. Their omnipresence across medical settings marks them as essential commodities in global health.

Request to Get the Sample Report: https://www.imarcgroup.com/antibiotics-market/requestsample

What are the growth prospects and trends in the antibiotics industry?

The escalating prevalence of bacterial infections majorly drives the global market. This can be supported by the emergence of antibiotic-resistant strains, which necessitate the development of new and more potent antibiotics. The market is also experiencing an upswing due to an aging global population, who are more susceptible to infections and thus require antibiotic intervention more frequently. Along with this, advances in biotechnology have opened avenues for discovering novel antibiotics, further amplifying market growth. Additionally, growing healthcare investments in emerging economies and increased government funding for research and development in the antibiotic sector are promising indicators for market expansion. Furthermore, the onset of telemedicine and online pharmacies has made antibiotics more accessible, boosting sales and market spread.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/antibiotics-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• Allergan Plc (AbbVie Inc.)
• Basilea Pharmaceutica AG
• GlaxoSmithKline Plc
• Johnson & Johnson
• Melinta Therapeutics
• Merck & Co. Inc.
• Nabriva Therapeutics Plc
• Paratek Pharmaceuticals Inc.
• Pfizer Inc.
• Sanofi SA
• Spero Therapeutics
• Tetraphase Pharmaceuticals

Antibiotics Market Segmentation:

Our report has categorized the market based on region, action mechanism, drug class, spectrum of activity, route of administration and end user.

Breakup by Action Mechanism:
• Cell Wall Synthesis Inhibitors
• Protein Synthesis Inhibitors
• DNA Synthesis Inhibitors
• RNA Synthesis Inhibitors
• Mycolic Acid Inhibitors
• Others

Breakup by Drug Class:
• Cephalosporin
• Penicillin
• Fluoroquinolone
• Macrolide
• Carbapenem
• Aminoglycoside
• Others

Breakup by Spectrum of Activity:
• Broad-Spectrum Antibiotics
• Narrow-Spectrum Antibiotics

Breakup by Route of Administration:
• Oral
• Parenteral
• Topical
• Others

Breakup by End User:
• Hospitals
• Specialty Clinics
• Others

Breakup by Region:
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:
• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.